GoHealth, Inc.(GOCO)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #2,715 of 2,879 stocks
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
GOCO Stock Analysis & AI Quality Score
AI stock analysis and institutional research for GoHealth, Inc. (GOCO), a Financials sector company. 13F Pro's AI-powered ranking engine scores GOCO at 17.7/100 on a 32-signal composite quality model, placing it at rank #2,715 of 2,879 stocks — the bottom half of the AI-ranked universe. Areas of concern include revenue growth (5.0) and profitability (8.3), which score below median versus the broader universe. Shareholder dilution risk is elevated at 37.1/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q1 2026), GoHealth, Inc. reports quarterly revenue of $11.9M, net income of $-37.2M, free cash flow of $7.0M. Top institutional holders of GOCO by reported 13-F value include Centerbridge Partners, L.P., PUBLIC SECTOR PENSION INVESTMENT BOARD, REDWOOD CAPITAL MANAGEMENT,, based on the most recent SEC filings. GOCO trades on the Nasdaq exchange and files with the SEC under CIK 1808220. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate GOCO daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for GoHealth, Inc. directly from SEC EDGAR. GoHealth, Inc.'s 13F Pro composite quality score has ranged between 16 and 19 since 2026, currently 17.7 — a stable long-term trajectory across 10 quarterly and live scoring snapshots.
Revenue
Q1 2026
$11.9M
Net Income
Q1 2026
$-37.2M
Free Cash Flow
Q1 2026
$7.0M
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · Pro+Revenue
-54.7% YoYNet Income
-8681.6% YoYOperating Income
-5759.2% YoYEPS (Diluted)
-2956.1% YoYTotal Assets
-33.7% YoYTotal Debt
+20.9% YoYOp. Cash Flow
-464.4% YoY| Metric | FY 2025 | FY 2024 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Revenue | $361.8M -54.7% | $798.9M +26.5% | $631.7M -40.5% | $1.06B +21.1% | $877.4M | — |
| Net Income | $-257.1M -8681.6% | $-2.9M +98.0% | $-148.7M +21.5% | $-189.4M -327.8% | $-44.3M | — |
| Operating Income | $-412.9M -5759.2% | $-7.0M +97.8% | $-318.7M +34.9% | $-489.4M -658.3% | $-64.5M | — |
| EPS (Diluted) | $-20.17 -2956.1% | $-0.66 +96.3% | $-17.72 +33.9% | $-26.80 -700.0% | $-3.35 | — |
| Total Assets | $987.4M -33.7% | $1.49B -10.3% | $1.66B -19.8% | $2.07B -1.9% | $2.11B +31.6% | $1.60B |
| Total Debt | $636.7M +20.9% | $526.9M +2.2% | $515.4M -23.7% | $675.7M +66.9% | $404.7M +37.6% | $294.2M |
| Operating Cash Flow | $-121.9M -464.4% | $-21.6M -135.5% | $60.9M +120.4% | $-299.0M -161.8% | $-114.2M | — |
Get alerted when GOCO's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for GoHealth, Inc. including:
Top Institutional Holders of GOCO
Centerbridge Partners, L.P.
$6.3M4,179,850 shPUBLIC SECTOR PENSION INVESTMENT BOARD
$2.5M1,680,444 shREDWOOD CAPITAL MANAGEMENT, LLC
$1.4M924,244 shCDC Financial, Inc.
$1.1M753,033 shBlackRock, Inc.
$576.9K382,050 shGEODE CAPITAL MANAGEMENT, LLC
$357.7K236,873 shVANGUARD CAPITAL MANAGEMENT LLC
$282.0K186,762 shCorient Private Wealth LLC
$180.5K119,541 shSTATE STREET CORP
$119.1K78,869 shBARCLAYS PLC
$104.1K68,923 sh
| Fund | Value | Shares |
|---|---|---|
| Centerbridge Partners, L.P. | $6.3M | 4,179,850 |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | $2.5M | 1,680,444 |
| REDWOOD CAPITAL MANAGEMENT, LLC | $1.4M | 924,244 |
| CDC Financial, Inc. | $1.1M | 753,033 |
| BlackRock, Inc. | $576.9K | 382,050 |
| GEODE CAPITAL MANAGEMENT, LLC | $357.7K | 236,873 |
| VANGUARD CAPITAL MANAGEMENT LLC | $282.0K | 186,762 |
| Corient Private Wealth LLC | $180.5K | 119,541 |
| STATE STREET CORP | $119.1K | 78,869 |
| BARCLAYS PLC | $104.1K | 68,923 |
More Financials Companies
View all Financials →Put GOCO on your watchlist
Track score changes the day GoHealth, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is GOCO a good stock to buy?
13F Pro's AI-powered analysis of GoHealth, Inc. (GOCO) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Financials sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for GOCO are available on the GOCO stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own GOCO?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling GOCO. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of GoHealth, Inc.'s investment landscape.